Sophia Genetics was founded in 2011 to make Data-Driven Medicine a reality. With the adoption of digital technologies, such as Next Generation DNA Sequencing, the healthcare industry entered the Big Data world raising new challenges in data protection and data analytics. We quickly recruited a world class team of +130 talented individuals, building a cross-disciplinary team that could understand and address those challenges. We always bet on quality, going into the details of the data, and similarly to Swiss watch makers, developed extremely powerful and reliable technologies to reach the highest possible accuracy. As a result, we are today the only company in the field of genomics with both, ISO 13485 (Medical Devices Quality Management) and ISO 27001 (Information Security Management) certifications.
With over 300 hospitals using our Sophia DDM® analytics platform, we have created the World's Largest Clinical Genomics Community. Every week, we contribute in better diagnosing thousands of patients suffering from congenital disorders and cancer. We are passionate, act with integrity and make it our priority to offer patients the most accurate diagnosis of their disease so that they can receive the most effective treatments available.
Adrienne Corboud Fumagalli, Vice President for Innovation and Technology Transfer at EPFL: "Sophia Genetics is a Swiss success story, and at EPFL we are proud of its evolution from start-up launched in our Innovation Park, to established European market leader in genomic analysis."
Sophia Genetics gives you the most accurate analysis of your sequenced data. Whether you already own a NGS sequencer, or are just getting started with your lab, we have developed three comprehensive solutions for every situation in order to make sure every hospital can get access to our services.
SOPHiATM is the most advanced artificial intelligence AI for Data-Driven Medicine. SOPHiA processes raw genomic data to detect, annotate, and pre-classify variants to facilitate and accelerate clinician’s decisions. Through SOPHiA, knowledge silos are broken in a collective effort to democratize diagnosis to help clinicians better diagnose their patients. SOPHiA AI is only available through Sophia DDM® platform.
Sophia DDM® powered by SOPHiA AI, is a software-as-a-service platform designed to perform routine diagnostic testing with the following steps:
1. Create a request2. Interpretation3. Variants Report
It enables analysis and protection of clinical NGS data. Our core technologies process and analyse raw genomic data to help hospitals accurately and speedily diagnose patients in areas including oncology, metabolism, pediatrics, cardiology and hereditary cancer.
Sophia Genetics brings together experts in genomics, machine learning and clinical diagnostics to simplify and optimise the use of clinical genomics tests. Our data-rich platform allows knowledge sharing that benefits all patients. We are creating the World’s Largest Genomics Community with over 300 hospitals linked by the use of Sophia DDM®.